VanEck Launches Europes First Bionic Engineering Healthcare ETF

VanEck has just announced the launch of the first ETF in Europe to target bionic engineering in the healthcare industry. The VanEck Bionic Engineering UCITS ETF (CYBO) is now available for trade on the London Stock Exchange and Deutsche Boerse with an expense ratio of 0.55%. As the name suggests, CYBO will track the MVIS Global Bionic Healthcare ESG index that gives exposure to the 25 biggest liquid companies in medical, dental/visual implants, prosthetics, and bioprinting. CYBO’s three largest positions are, Dexcom, Stryker, and Edwards Lifesciences.

ETF Newz Says:

The index blacklists companies that “very severely violate” the UN Global Compact Principles or those that receive revenue from controversial weapons, fossil fuels, nuclear power, oil sands, military equipment, and tobacco.

Heavily Traded ETFs
SPDR S&P 500 - SPY
Invesco QQQ
Vanguard S&P 500 - VOO
Vanguard Total Market - VTI
Energy Select Sector - XLE

Vanguard Expands Active Fixed Income ETF Lineup with New Offerings

Vanguard, a prominent player in the asset management industry, is further bolstering its presence in the active fixed...

VanEck Launches Office and Commercial REIT ETF (DESK)

VanEck, a firm known for its ETF offerings, has launched the VanEck Office and Commercial REIT ETF (DESK),...

Roundhill Investments Launches First LNG-Focused ETF as Europe Shifts Away From Russian Gas

Roundhill Investments has introduced the Roundhill Alerian LNG ETF (LNGG), the first exchange-traded fund (ETF) to focus on...

Matthews Asia Launches Five Actively Managed Emerging Market ETFs

Matthews Asia, an investment firm focused on Asia, has introduced five new actively managed exchange-traded funds (ETFs) aimed...